PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Diabetes drug could work against Alzheimer's

2010-11-25
(Press-News.org) Bonn, 24th November 2010. Metformin, a drug used in type 2-diabetes might have the potential to also act against Alzheimer's disease. This has been shown in a study from scientists of the German Center for Neurodegenerative Diseases (DZNE), the University of Dundee and the Max-Planck-Institute for Molecular Genetics. The researchers have found out that the diabetes drug metformin counteracts alterations of the cell structure protein Tau in mice nerve cells. These alterations are a main cause of the Alzheimer's disease. Moreover, they uncovered the molecular mechanism of metformin in this process. "If we can confirm that metformin shows also an effect in humans, it is certainly a good candidate for an effective therapy on Alzheimer's diseases," says Sybille Krauß from DZNE. Their results have been published in the scientific journal PNAS on November 22nd.

Alzheimer's disease is a form of dementia that affects almost exclusively elderly people. Today, about 700,000 people are suffering from Alzheimer's disease in Germany. Neurons in their brains die, leading to cognitive impairment. At the molecular level, the disease is characterized amongst others by the formation of Tau protein deposits in nerve cells. Tau is a molecule that usually binds to the supportive cytoskeleton and performs a function in the transport system of the cell. In Alzheimer's disease, Tau is tipped too strongly with phosphate groups. This phosphorylation causes removal of Tau from the cytoskeleton and aggregation.

To counteract this problem, researchers aimed at regulating the protein PP2A. This protein is normally responsible for removing phosphate groups from Tau protein. In Alzheimer's disease, PP2A is not active enough – leading to an increased phosphorylation and deposition of Tau. The scientists around Sybille Krauss and Susann Schweiger (University of Dundee) therefore looked for a drug that increases the activity of PP2A. "So far there is no drug on the market that targets the formation of tau aggregates," says Krauß.

In cell culture experiments with mouse nerve cells, the researchers showed that metformin directly protects PP2A against degradation by preventing the binding to special degradation proteins. This mechanism of metformin has been unknown so far. In addition, an increase in PP2A activity leads to a reduction in Tau phosphorylation. In a next step, the scientists added metformin to drinking water of healthy mice. This also led to a reduction of Tau-phoshorylation in brain cells. In further experiments, the researchers now intend to investigate, whether metformin prevents the deposition of tau proteins also in mouse models of Alzheimer's disease and improves cognitive performance of the animals. The effect in humans will then be tested in clinical studies. There is no risk of unexpected side effects, due to the fact that the drug is already used against diabetes.

INFORMATION:

Original publication:

Kickstein E, Krauss S, Thornhill P, Rutschow D, Zeller R, Sharkey J, Williamson R, Fuchs M, Köhler A, Glossmann H, Schneider R, Sutherland C, Schweiger S: The Biguanide metformin acts on tau phosphorylation via mTOR/PP2A signalling. PNAS published ahead of print November 22, 2010, doi:10.1073/pnas.0912793107.

Contact.
Dr. Sybille Krauß
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)
c/o Uniklinik Bonn / Neurologie
Sigmund-Freud-Str.25
53127 Bonn
Tel.: +49 228 287 19534
Email: sybille.krauss@dzne.de

Prof. Susann Schweiger (MD)
Professor of Molecular Medicine
Division of Medical Sciences
Ninewells Hospital & Medical School
University of Dundee
DD1 9SY Dundee
, UK
Tel.: +44 1382 496235
Email: s.schweiger@dundee.ac.uk

Dr. Katrin Weigmann
Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
Presse- und Öffentlichkeitsarbeit
Tel.: +49 228 43302 263
mobil: +49 172 2838930
Email: katrin.weigmann@dzne.de
Web: www.dzne.de

END



ELSE PRESS RELEASES FROM THIS DATE:

Female fish -- and humans? -- lose interest when their male loses a slugfest

Female fish -- and humans? -- lose interest when their male loses a slugfest
2010-11-25
You may think of your love for your mate as the noble emotion of a pure heart, but some primitive parts of your brain are taking a decidedly more pragmatic approach to the subject, according to Stanford biologists. In experiments with African cichlid fish, the scientists discovered that when a female shows a preference for a particular male, but then witnesses him losing a fight with another male, her feelings toward him change. Areas of the female's brain associated with anxiety showed increased activity after witnessing an altercation. "It is the same as if a woman ...

New study reveals how cannabis suppresses immune functions

2010-11-25
An international team of immunologists studying the effects of cannabis have discovered how smoking marijuana can trigger a suppression of the body's immune functions. The research, published in the European Journal of Immunology, reveals why cannabis users are more susceptible to certain types of cancers and infections. The team, led by Dr Prakash Nagarkatti from the University of South Carolina, focused their research on cannabinoids, a group of compounds found inside the cannabis plant, including THC (delta-9 tetahydrocannabinol) which is already used for medical ...

When Belgium sneezes, the world catches a cold

2010-11-25
As the eurozone continues to wobble, new analysis of countries' economic interconnectedness finds that some of the countries with the greatest potential to cause a global crash have surprisingly small gross domestic production. Using data from Bureau Van Dijk - the company information and business intelligence provider - to assess the reach and size of different countries' economies, and applying the Susceptible-Infected-Recovered (SIR) model, physicists from universities in Greece, Switzerland and Israel have identified the twelve countries with greatest power to spread ...

Heavy metals in seafood: Satisfactory results of interlaboratory comparison

2010-11-25
Fifty-seven laboratories from 29 countries volunteered to put their measuring competence to the test. Each laboratory received a sample without knowing the levels of heavy metals present, and was asked to measure and report the values back to the JRC. The good results should enhance consumers' confidence, as maximum levels of lead, cadmium and total mercury in seafood are regulated by EU law and it has been proven that most participants are able to correctly measure them. In addition, this comparison has highlighted other issues, such as the apparent dependency of the ...

The most aggressive forms of breast cancer elude cellular control mechanisms in order to expand

2010-11-25
About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes. Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth. The study is published this week in the ...

Experts urge US to create emergency cholera vaccine stockpile for humanitarian use

2010-11-25
In the wake of devastating cholera outbreaks in refugee camps in earthquake-wracked Haiti, a group of leading experts from Harvard Medical School, George Washington University, and the International Vaccine Institute (IVI) have urged the United States to create an emergency stockpile of cholera vaccines for future humanitarian use. "The costs to the U.S. of creating and maintaining a stockpile of several million doses of cholera vaccine would be low," said the experts in an article published online first on November 24 in The New England Journal of Medicine (NEJM). "But ...

Dartmouth study uses the patient's tumor to form vaccine

2010-11-25
A new process for creating a personalized vaccine may become a crucial tool in helping patients with colorectal cancer develop an immune response against their own tumors. This dendritic cell (DC) vaccine, developed at Dartmouth and described in a research paper published this week in the journal Clinical Cancer Research, was used after surgical resection of metastatic tumors to try to prevent the growth of additional metastases. "The results of the study suggest a new way to approach cancer treatment," said Richard Barth Jr., MD, Chief of General Surgery at Dartmouth-Hitchcock ...

Overseas lab seeks US weed control 'recruits'

2010-11-25
The search is on for insects, mites, microbes or nematodes that could be used in a biologically based approach to controlling silverleaf nightshade, an invasive weed from the Americas that has spread to southern Europe, Africa, India, Australia and elsewhere. According to U.S. Department of Agriculture (USDA) entomologist Walker Jones, the perennial weed, Solanum elaeagnifolium, is being targeted for its ability to outcompete native plants, reduce crop yields and diminish pasture productivity. Its orange, toxin-producing berries can also poison livestock. Severe infestations ...

Chronic high cholesterol diet produces brain damage

2010-11-25
London, UK, 24 November 2010 – Research from the Laboratory of Psychiatry and Experimental Alzheimers Research (http://www2.i-med.ac.at/psychlab/) at the Medical University Innsbruck (Austria) demonstrated that chronic high fat cholesterol diet in rats exhibited pathologies similar to Alzheimer's disease. The results were published in Molecular Cellular Neuroscience (45(4):408-417, 2010) with lead author Dr. Christian Humpel. The study was co-authored by PhD students, Celine Ullrich and Michael Pirchl, from the same Laboratory. Alzheimer's disease is a severe neurodegenerative ...

Mildew-resistant and infertile

Mildew-resistant and infertile
2010-11-25
Mildew infections not only cause unsightly vegetable patches, they can also result in extensive crop failure. Interestingly, the processes involved in infections with this garden pest are similar to those involved in fertilisation. Scientists from the Max Planck Institute for Plant Breeding Research in Cologne and the University of Zurich have identified two proteins in the model plant species Arabidopsis thaliana that are necessary for both fertilisation and infection with powdery mildew. This explains why mildew-resistant plants, in which these genes are mutated, are ...

LAST 30 PRESS RELEASES:

Rugged Falklands landscape was once a lush rainforest

Dizziness in older adults is linked to higher risk of future falls

Triptans more effective than newer, more expensive migraine drugs

Iron given through the vein corrects iron deficiency anaemia in pregnant women faster and better than iron taken by mouth

The Lancet Neurology: Air pollution, high temperatures, and metabolic risk factors driving global increases in stroke, with latest figures estimating 12 million cases and over 7 million deaths from st

Incidence of neuroleptic malignant syndrome during antipsychotic treatment in children and youth

Levels of protection from different cycle helmets revealed by new ratings

Pupils with SEND continue to fall behind their peers

Half of heavier drinkers say calorie labels on alcohol would lead to a change in their drinking habits

Study first to link operating room design to shorter surgery

New study uncovers therapeutic inertia in the treatment of women with multiple sclerosis

Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer

Nawaz named ASME Fellow

U2opia signs license to commercialize anomaly-detection technology for cybersecurity

Explaining dramatic planetwide changes after world’s last ‘Snowball Earth’ event

Cleveland Clinic study is first to show success in treating rare blood disorder

Bone marrow cancer drug shows success in treatment of rare blood disorder

Clinical trial successfully repurposes cancer drug for hereditary bleeding disorder

UVA Engineering professor awarded $1.6M EPA grant to reduce PFAS accumulation in crops

UVA professor receives OpenAI grant to inform next-generation AI systems

New website helps researchers overcome peer reviewers’ preference for animal experiments

Can the MIND diet lower the risk of memory problems later in life?

Some diabetes drugs tied to lower risk of dementia, Parkinson’s disease

Propagated corals reveal increased resistance to bleaching across the Caribbean during the fatal heatwave of 2023

South African rock art possibly inspired by long-extinct species

Even marine animals in untouched habitats are at risk from human impacts

Hexagonal electrohydraulic modules shape-shift into versatile robots

Flexible circuits made with silk and graphene on the horizon

Scott Emr and Wesley Sundquist awarded 2024 Horwitz Prize for discovering the ESCRT pathway

Versatile knee exo for safer lifting

[Press-News.org] Diabetes drug could work against Alzheimer's